Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 78

1.

End of life care for glioblastoma patients at a large academic cancer center.

Kuchinad KE, Strowd R, Evans A, Riley WA, Smith TJ.

J Neurooncol. 2017 Aug;134(1):75-81. doi: 10.1007/s11060-017-2487-8. Epub 2017 May 20.

PMID:
28528421
2.

True healing for the hospice patient.

Riley WA.

Md Med. 2010 Winter;11(1):21-2. No abstract available.

PMID:
21140863
3.

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.

Bots ML, Visseren FL, Evans GW, Riley WA, Revkin JH, Tegeler CH, Shear CL, Duggan WT, Vicari RM, Grobbee DE, Kastelein JJ; RADIANCE 2 Investigators.

Lancet. 2007 Jul 14;370(9582):153-160. doi: 10.1016/S0140-6736(07)61088-5.

PMID:
17630038
4.

Designs of RADIANCE 1 and 2: carotid ultrasound studies comparing the effects of torcetrapib/atorvastatin with atorvastatin alone on atherosclerosis.

Kastelein JJ, van Leuven SI, Evans GW, Riley WA, Revkin JH, Shear CL, Bots ML; RADIANCE 1 and 2 Study Investigators.

Curr Med Res Opin. 2007 Apr;23(4):885-94.

PMID:
17407645
5.

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.

Kastelein JJ, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE, Riley WA, Shear CL, Duggan WT, Bots ML; RADIANCE 1 Investigators.

N Engl J Med. 2007 Apr 19;356(16):1620-30. Epub 2007 Mar 26.

6.

Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.

Crouse JR 3rd, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML; METEOR Study Group.

JAMA. 2007 Mar 28;297(12):1344-53. Epub 2007 Mar 25.

PMID:
17384434
7.

Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study.

Crouse JR 3rd, Grobbee DE, O'Leary DH, Bots ML, Evans GW, Palmer MK, Riley WA, Raichlen JS; METEOR Study Group.

Curr Med Res Opin. 2007 Mar;23(3):641-8.

PMID:
17355745
8.

From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.

Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, Fayad Z, Budoff MJ, Rumberger J, Naqvi TZ, Shaw LJ, Faergeman O, Cohn J, Bahr R, Koenig W, Demirovic J, Arking D, Herrera VL, Badimon J, Goldstein JA, Rudy Y, Airaksinen J, Schwartz RS, Riley WA, Mendes RA, Douglas P, Shah PK; SHAPE Task Force.

Am J Cardiol. 2006 Jul 17;98(2A):2H-15H. Epub 2006 Jun 12. Review.

PMID:
16843744
9.

Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study.

Crouse JR 3rd, Grobbee DE, O'Leary DH, Bots ML, Evans GW, Palmer MK, Riley WA, Raichlen JS; Measuring Effects on intima media Thickness: an Evalution Of Rosuvastatin study group.

Cardiovasc Drugs Ther. 2004 May;18(3):231-8.

PMID:
15229392
10.
11.
12.

Heritability of carotid artery intima-medial thickness in type 2 diabetes.

Lange LA, Bowden DW, Langefeld CD, Wagenknecht LE, Carr JJ, Rich SS, Riley WA, Freedman BI.

Stroke. 2002 Jul;33(7):1876-81.

PMID:
12105369
13.

Carotid intima-media thickness: risk assessment and scanning protocol.

Riley WA.

Eur Heart J. 2002 Jun;23(12):916-8. No abstract available.

PMID:
12069441
14.

Estrogen replacement and brachial artery flow-mediated vasodilation in older women.

Herrington DM, Espeland MA, Crouse JR 3rd, Robertson J, Riley WA, McBurnie MA, Burke GL.

Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1955-61.

PMID:
11742870
15.
16.

Brachial flow-mediated vasodilator responses in population-based research: methods, reproducibility and effects of age, gender and baseline diameter.

Herrington DM, Fan L, Drum M, Riley WA, Pusser BE, Crouse JR, Burke GL, McBurnie MA, Morgan TM, Espeland MA.

J Cardiovasc Risk. 2001 Oct;8(5):319-28.

PMID:
11702039
17.

Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia.

Hopkins PN, Stephenson S, Wu LL, Riley WA, Xin Y, Hunt SC.

Am J Cardiol. 2001 Mar 1;87(5):547-53.

PMID:
11230837
18.

Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women.

Herrington DM, Pusser BE, Riley WA, Thuren TY, Brosnihan KB, Brinton EA, MacLean DB.

Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1606-12.

PMID:
10845879
19.

Effects of mental stress on brachial artery flow-mediated vasodilation in healthy normal individuals.

Harris CW, Edwards JL, Baruch A, Riley WA, Pusser BE, Rejeski WJ, Herrington DM.

Am Heart J. 2000 Mar;139(3):405-11.

PMID:
10689254
20.

Arterial stiffness and the development of hypertension. The ARIC study.

Liao D, Arnett DK, Tyroler HA, Riley WA, Chambless LE, Szklo M, Heiss G.

Hypertension. 1999 Aug;34(2):201-6.

PMID:
10454441

Supplemental Content

Loading ...
Support Center